CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
US$19,12
arrow_downward
-0,21%(-0,040) 1D
US$19,34
arrow_upward
+1,12% (+0,22)todayPre-market
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
US$19,22
High
US$19,25
Low
US$18,94
Mkt. cap
10,36ລລ
Avg. vol.
304,28 ພັນ
Volume
90,00 ພັນ
52-wk high
US$34,84
52-wk low
US$18,94
Beta
0,56
Shares outstanding
3,36 ຕື້
No. of employees
5 ພັນ
Open
US$19,22
High
US$19,25
Low
US$18,94
Mkt. cap
10,36ລລ
Avg. vol.
304,28 ພັນ
Volume
90,00 ພັນ
52-wk high
US$34,84
52-wk low
US$18,94
Beta
0,56
Shares outstanding
3,36 ຕື້
No. of employees
5 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
4 ຊົ່ວໂມງກ່ອນ
Chugai reports Week 52 vamikibart data for Chugai Pharmaceutical stock
ad-hoc-news.de
·
5 ຊົ່ວໂມງກ່ອນ
Chugai Pharmaceutical reports Week 52 vamikibart data: stock pre-market at EUR 34.84
ad-hoc-news.de
·
16 ຊົ່ວໂມງກ່ອນ
Chugai Pharmaceutical stock after-hours at EUR 33.94
ad-hoc-news.de
·
1 ມື້ກ່ອນ
Chugai Pharmaceutical stock at EUR 34.02, market value JPY 9.9 trillion
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5,1 ພັນ
Founded10 ມ.ນ. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp